Literature DB >> 9644255

Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells.

T Shimo1, T Nakanishi, Y Kimura, T Nishida, K Ishizeki, T Matsumura, M Takigawa.   

Abstract

Previously, we cloned an mRNA predominantly expressed in hypertrophic chondrocytes by differential display-PCR from a human chondrosarcoma-derived chondrocytic cell line (HCS-2/8) that is identical to that of connective tissue growth factor (CTGF). In the present study, we investigated the roles of CTGF in the proliferation and migration of vascular endothelial cells using its antisense oligonucleotide and antisense RNA, because angiogenesis into the hypertrophic zone of cartilage occurs at the final step of endochondral ossification. Immunohistochemical and immunofluorescence techniques revealed that not only hypertrophic chondrocytes but also endothelial cells in the cost-chondral junctions of mouse ribs were stained with an anti-CTGF antibody in vivo. Northern blot analysis revealed that CTGF was strongly expressed in chondrocytic cells as well as bovine aorta endothelial (BAE) cells in culture, but not in other types of cells such as osteoblastic cells. Its expression in BAE cells was greater in the growing phase than in the confluent phase. When one-half of a monolayer of a confluent culture of BAE cells had been peeled off, only the cells proliferating and extending into the vacant area were stained with the anti-CTGF antibody. The addition of an antisense oligonucleotide inhibited the proliferation and extension of the BAE cells into the vacant area. The antisense oligonucleotide also inhibited the proliferation of BAE cells in the rapidly proliferating phase. In a Boyden chamber assay, pretreatment with the antisense oligonucleotide markedly inhibited the migration of BAE cells. Furthermore, the abilities to proliferate and migrate of BAE cells, which were stably transfected with expression vectors that generate the antisense RNA of CTGF cDNA, were markedly lower than those of the control. These findings suggest that endogenous CTGF expression is involved in the proliferation and migration of BAE cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9644255     DOI: 10.1093/oxfordjournals.jbchem.a022071

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  25 in total

Review 1.  NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues.

Authors:  B Perbal
Journal:  Mol Pathol       Date:  2001-04

2.  Temporal and spatial expression of connective tissue growth factor (CCN2; CTGF) and transforming growth factor beta type 1 (TGF-beta1) at the utero-placental interface during early pregnancy in the pig.

Authors:  E E-D A Moussad; M A E Rageh; A K Wilson; R D Geisert; D R Brigstock
Journal:  Mol Pathol       Date:  2002-06

3.  Physical interaction of CCN2 with diverse growth factors involved in chondrocyte differentiation during endochondral ossification.

Authors:  Hany Mohamed Khattab; Eriko Aoyama; Satoshi Kubota; Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2015-04-19       Impact factor: 5.782

4.  Connective tissue growth factor is required for normal follicle development and ovulation.

Authors:  Takashi Nagashima; Jaeyeon Kim; Qinglei Li; John P Lydon; Francesco J DeMayo; Karen M Lyons; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2011-08-25

5.  The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts.

Authors:  A Leask; S Sa; A Holmes; X Shiwen; C M Black; D J Abraham
Journal:  Mol Pathol       Date:  2001-06

6.  CCN2 as a novel molecule supporting energy metabolism of chondrocytes.

Authors:  Aya Maeda-Uematsu; Satoshi Kubota; Harumi Kawaki; Kazumi Kawata; Yoshiaki Miyake; Takako Hattori; Takashi Nishida; Norifumi Moritani; Karen M Lyons; Seiji Iida; Masaharu Takigawa
Journal:  J Cell Biochem       Date:  2014-05       Impact factor: 4.429

7.  A novel primate model of delayed wound healing in diabetes: dysregulation of connective tissue growth factor.

Authors:  S E Thomson; S V McLennan; A Hennessy; P Boughton; J Bonner; H Zoellner; D K Yue; S M Twigg
Journal:  Diabetologia       Date:  2009-11-29       Impact factor: 10.122

8.  Restoration of murine femoral segmental defect using CTGF-overexpressing MC3T3-E1 cells.

Authors:  Xiangyu Huang; Yanqiu Li; Jiantao Xu; Kai Liu; Xin Yu; Xin Cheng; Dongdong Xu; Zubing Li
Journal:  Am J Transl Res       Date:  2016-03-15       Impact factor: 4.060

9.  Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL-mutant renal carcinoma cells.

Authors:  Mastan R Chintalapudi; Margaret Markiewicz; Nurgun Kose; Vincent Dammai; Kristen J Champion; Rana S Hoda; Maria Trojanowska; Tien Hsu
Journal:  Carcinogenesis       Date:  2008-01-22       Impact factor: 4.944

Review 10.  An early history of CCN2/CTGF research: the road to CCN2 via hcs24, ctgf, ecogenin, and regenerin.

Authors:  Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2017-10-26       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.